Baird’s Medtronic MDT Stock Holding History

Baird’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$9.84M	Buy	126,212 +52,967	+72%	+$4.01M	0.1%	212
2014 Q4	$5.29M	Buy	73,245 +15,248	+26%	+$1.06M	0.06%	322
2014 Q3	$3.59M	Sell	57,997 -41,948	-42%	-$2.67M	0.05%	316
2014 Q2	$6.37M	Sell	99,945 -37,555	-27%	-$2.28M	0.09%	212
2014 Q1	$8.46M	Sell	137,500 -2,015	-1%	-$117K	0.12%	181
2013 Q4	$8.01M	Buy	139,515 +100	+0.1%	+$5.67K	0.14%	182
2013 Q3	$7.42M	Buy	139,415 +869	+0.6%	+$46.8K	0.14%	195
2013 Q2	$7.13M	Buy	+138,546	New	+$6.85M	0.14%	195

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baird's MDT Position: Q1 2015 in Review

Baird increased its Medtronic (MDT) stake by 72% in Q1 2015, buying an estimated $4.01M and bringing the position to 126,212 shares worth $9.84M. The position accounts for 0.1% of the portfolio, ranked #212.

Baird first reported a position in MDT in Q2 2013 and has held it in 8 quarters since. 1,245 funds tracked by Wall St. Rank hold MDT as of Q1 2015.

Baird held 126,212 shares of Medtronic worth $9.84M as of Q1 2015.
Baird bought 52,967 Medtronic shares in Q1 2015, an estimated $4.01M.
Medtronic made up 0.1% of Baird's portfolio in Q1 2015, its #212 holding.
Baird first reported a position in Medtronic in Q2 2013 and has held it in 8 quarters since.
1,245 funds tracked by Wall St. Rank held Medtronic as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.